Literature DB >> 33074415

Transdermal peptide conjugated to human connective tissue growth factor with enhanced cell proliferation and hyaluronic acid synthesis activities produced by a silkworm silk gland bioreactor.

Yuancheng Wang1,2, Feng Wang1,2,3, Sheng Xu1,2, Riyuan Wang1,2, Chi Tian1,2, Yanting Ji1,2, Qianqian Yang1,2, Ping Zhao1,2, Qingyou Xia4,5,6.   

Abstract

Human connective tissue growth factor (CTGF) is a secreted cysteine-rich peptide that stimulates cell proliferation, migration, and extracellular matrix production during tissue development, differentiation, angiogenesis, implantation, wound healing, and fibrosis processes, with broad application in the medical and cosmetic medical fields. However, the production of CTGF is currently limited by its low yield and purity in current bioreactors. In this study, two genetically modified silkworm strains were generated harboring artificially designed CTGF-8ht and pepCTGF-8ht genes, respectively, that contain an enhanced His-tag with eight histidine residues with or without a transdermal peptide (pep). Both recombinant CTGF-8ht and pepCTGF-8ht proteins were successfully expressed in the silkworm silk gland and cocoon, and could be easily extracted and purified from the cocoon by single-affinity immunoprecipitation column chromatography, achieving a purity of more than 95%. Moreover, compared with CTGF-8ht protein, pepCTGF-8ht protein exhibited better cell proliferation activity by activating the extracellular signal-regulated kinase (ERK) pathway and enhanced hyaluronic acid synthesis activity by upregulating hyaluronan synthase 3 expression; moreover, the addition of pep significantly improved the transmembrane ability of CTGF-8ht protein. These results should help to promote the application prospects of CTGF and further guide the design and development of protein drugs from silkworm and other bioreactor systems. KEY POINTS : A silkworm bioreactor was optimized to produce connective tissue growth factor (CTGF) The transgene contained an enhanced 8-His-tag and transmembrane peptide (pep) Recombinant CTGF was easily purified with maintained or higher biological activity.

Entities:  

Keywords:  Genetic engineering; Human connective tissue growth factor; Silkworm silk gland bioreactor; Transdermal peptide

Mesh:

Substances:

Year:  2020        PMID: 33074415     DOI: 10.1007/s00253-020-10836-0

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  44 in total

Review 1.  FGF signals for cell proliferation and migration through different pathways.

Authors:  B Boilly; A S Vercoutter-Edouart; H Hondermarck; V Nurcombe; X Le Bourhis
Journal:  Cytokine Growth Factor Rev       Date:  2000-12       Impact factor: 7.638

2.  Expression of biologically active human interferon gamma in the milk of transgenic mice under the control of the murine whey acidic protein gene promoter.

Authors:  Haydar Bagis; Digdem Aktoprakligil; Cagatay Gunes; Sezen Arat; Tolga Akkoc; Gaye Cetinkaya; Orhan Kankavi; Ali Cihan Taskin; Korhan Arslan; Munis Dundar; Vania L Tsoncheva; Ivan G Ivanov
Journal:  Biochem Genet       Date:  2010-12-18       Impact factor: 1.890

3.  Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo.

Authors:  A M Babic; C C Chen; L F Lau
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

4.  Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor.

Authors:  K Frazier; S Williams; D Kothapalli; H Klapper; G R Grotendorst
Journal:  J Invest Dermatol       Date:  1996-09       Impact factor: 8.551

5.  Establishment of a recombinant expression system for connective tissue growth factor (CTGF) that models CTGF processing in utero.

Authors:  D K Ball; E E-D A Moussad; M A E Rageh; S A Kemper; D R Brigstock
Journal:  Reproduction       Date:  2003-02       Impact factor: 3.906

6.  In vivo protein transduction: biologically active intact pep-1-superoxide dismutase fusion protein efficiently protects against ischemic insult.

Authors:  Won Sik Eum; Dae Won Kim; In Koo Hwang; Ki-Yeon Yoo; Tae-Cheon Kang; Sang Ho Jang; Hee Soon Choi; Soo Hyun Choi; Young Hoon Kim; So Young Kim; Hyeok Yil Kwon; Jung Hoon Kang; Oh-Shin Kwon; Sung-Woo Cho; Kil Soo Lee; Jinseu Park; Moo Ho Won; Soo Young Choi
Journal:  Free Radic Biol Med       Date:  2004-11-15       Impact factor: 7.376

Review 7.  Production of recombinant proteins by microbes and higher organisms.

Authors:  Arnold L Demain; Preeti Vaishnav
Journal:  Biotechnol Adv       Date:  2009-01-31       Impact factor: 14.227

Review 8.  Secretory and extracellular production of recombinant proteins using Escherichia coli.

Authors:  J H Choi; S Y Lee
Journal:  Appl Microbiol Biotechnol       Date:  2004-02-14       Impact factor: 4.813

9.  Human connective tissue growth factor expressed in Escherichia coli is a non-mitogenic inhibitor of apoptosis.

Authors:  Daniel Gygi; Peter Zumstein; Doris Grossenbacher; Lukas Altwegg; Thomas F Lüscher; Heinz Gehring
Journal:  Biochem Biophys Res Commun       Date:  2003-11-21       Impact factor: 3.575

10.  Tat-mediated delivery of heterologous proteins into cells.

Authors:  S Fawell; J Seery; Y Daikh; C Moore; L L Chen; B Pepinsky; J Barsoum
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 12.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.